<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000532133"><TermName>tetra-O-methyl nordihydroguaiaretic acid</TermName><TermPronunciation>(TEH-truh-O-MEH-thul NOR-dy-HY-droh-GWY-uh-reh-tik A-sid)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It blocks proteins needed for cancer growth. It is a type of transcriptional inhibitor. Also called EM-1421 and tetra-O-methyl NDGA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718668" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tetra-O-methyl nordihydroguaiaretic acid&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718667" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ácido nordihidroguaiarético tretra-O-metilo&quot;" language="es" id="_4"/><SpanishTermName>ácido nordihidroguaiarético tretra-O-metilo</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Bloquea las proteínas que el cáncer necesita para crecer. Es un tipo de inhibidor de la transcripción. También se llama ácido NDGA tetra-O-metilo y EM-1421.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-06-21</DateFirstPublished></GlossaryTerm>
